Phase Ib of L-NMMA and Pembrolizumab
The Methodist Hospital Research Institute
The Methodist Hospital Research Institute
Fondazione del Piemonte per l'Oncologia
Fondazione del Piemonte per l'Oncologia
Mayo Clinic
Stanford University
Mayo Clinic
University of Kentucky
OHSU Knight Cancer Institute
Baylor College of Medicine
University of California, Davis
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Grey Wolf Therapeutics
Mayo Clinic
West China Hospital
University of Southern California
Roswell Park Cancer Institute
University of Pittsburgh
University of Southern California
Thomas Jefferson University
NuCana plc
Oslo University Hospital
National Cancer Centre, Singapore
Thomas Jefferson University
Thomas Jefferson University
Gustave Roussy, Cancer Campus, Grand Paris
Shandong Cancer Hospital and Institute
SOLTI Breast Cancer Research Group
UNICANCER
National University Hospital, Singapore
CNAO National Center of Oncological Hadrontherapy
Cancer Research UK
Zhejiang Provincial People's Hospital
Comprehensive Support Project for Oncology Research
Ohio State University Comprehensive Cancer Center
University of California, San Francisco
Sun Yat-sen University
Rutgers, The State University of New Jersey
Massachusetts General Hospital
Providence Health & Services
H. Lee Moffitt Cancer Center and Research Institute
Herlev Hospital
Institut du Cancer de Montpellier - Val d'Aurelle
Centre Leon Berard
Institut Bergonié
University Health Network, Toronto
Oncology Institute of Southern Switzerland
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Loma Linda University
Alliance for Clinical Trials in Oncology